BUY Varun Beverages Limited — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))22 Apr 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Varun Beverages Limited announced its financial results for Q1 CY2026, reporting an 18.1% YoY revenue growth to Rs. 65,741.9 million and a 21.0% YoY EBITDA increase to Rs. 15,289.3 million. The compan
NSE · Press Release·27 Apr · today
Varun Beverages Limited announced an interim dividend of ₹0.50 per equity share for FY2026. The record date for this dividend is May 1, 2026, and payment will commence on May 5, 2026. The company also
NSE · Outcome of Board Meeting·27 Apr · today
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Varun Beverages
- BUY — Kunal Parar, Choice Broking13 Oct 2026 · ~2 weeks · target ₹453 · SL hit
- BUY — Kunal Saraogi12 Oct 2026 · ~2 weeks · target ₹452 · SL hit
- BUY — Rupak De, LKP Securities9 Oct 2026 · ~2 weeks · target ₹460 · SL hit
- BUY — Kunal Saraogi8 Oct 2026 · Same day · target ₹448 · SL hit
- BUY — Laxmikant Shukla, YES Securities7 Oct 2026 · ~2 weeks · target ₹460 · SL hit
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

